Tissue transglutaminase links TGF-Β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Tissue transglutaminase (TG2), an enzyme involved in cell proliferation, differentiation and apoptosis is overexpressed in ovarian carcinomas, where it modulates epithelial-to-mesenchymal transition (EMT) and promotes metastasis. Its regulation in ovarian cancer (OC) remains unexplored. Here, we show that transforming growth factor (TGF)-Β, a cytokine involved in tumor dissemination is abundantly secreted in the OC microenvironment and induces TG2 expression and enzymatic activity. This is mediated at transcriptional level by SMADs and by TGF-Β-activated kinase 1-mediated activation of the nuclear factor-B complex. TGF-Β-stimulated OC cells aggregate as spheroids, which enable peritoneal dissemination. We show that TGF-Β-induced TG2 regulates EMT, formation of spheroids and OC metastasis. TG2 knock-down in OC cells decreases the number of cells harboring a cancer stem cell phenotype (CD44 +CD117+). Furthermore, CD44 +CD117+ cells isolated from human ovarian tumors express high levels of TG2. In summary, TGF-Β-induced TG2 enhances ovarian tumor metastasis by inducing EMT and a cancer stem cell phenotype.

Original languageEnglish (US)
Pages (from-to)2521-2534
Number of pages14
JournalOncogene
Volume31
Issue number20
DOIs
StatePublished - May 17 2012

Fingerprint

Epithelial-Mesenchymal Transition
Transforming Growth Factors
Ovarian Neoplasms
Stem Cells
Phenotype
Neoplastic Stem Cells
Neoplasm Metastasis
Neoplasms
Tumor Microenvironment
Cell Differentiation
Phosphotransferases
Cell Count
Cell Proliferation
transglutaminase 2
Apoptosis
Cytokines
Carcinoma
Enzymes

Keywords

  • cancer stem cells
  • epithelial to mesenchymal transition
  • metastasis
  • ovarian cancer
  • TG2
  • TGF-β

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Tissue transglutaminase links TGF-Β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. / Cao, L.; Shao, M.; Schilder, J.; Guise, T.; Mohammad, K. S.; Matei, D.

In: Oncogene, Vol. 31, No. 20, 17.05.2012, p. 2521-2534.

Research output: Contribution to journalArticle

@article{a92240dc1de54541b12fe451ad139365,
title = "Tissue transglutaminase links TGF-Β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer",
abstract = "Tissue transglutaminase (TG2), an enzyme involved in cell proliferation, differentiation and apoptosis is overexpressed in ovarian carcinomas, where it modulates epithelial-to-mesenchymal transition (EMT) and promotes metastasis. Its regulation in ovarian cancer (OC) remains unexplored. Here, we show that transforming growth factor (TGF)-Β, a cytokine involved in tumor dissemination is abundantly secreted in the OC microenvironment and induces TG2 expression and enzymatic activity. This is mediated at transcriptional level by SMADs and by TGF-Β-activated kinase 1-mediated activation of the nuclear factor-B complex. TGF-Β-stimulated OC cells aggregate as spheroids, which enable peritoneal dissemination. We show that TGF-Β-induced TG2 regulates EMT, formation of spheroids and OC metastasis. TG2 knock-down in OC cells decreases the number of cells harboring a cancer stem cell phenotype (CD44 +CD117+). Furthermore, CD44 +CD117+ cells isolated from human ovarian tumors express high levels of TG2. In summary, TGF-Β-induced TG2 enhances ovarian tumor metastasis by inducing EMT and a cancer stem cell phenotype.",
keywords = "cancer stem cells, epithelial to mesenchymal transition, metastasis, ovarian cancer, TG2, TGF-β",
author = "L. Cao and M. Shao and J. Schilder and T. Guise and Mohammad, {K. S.} and D. Matei",
year = "2012",
month = "5",
day = "17",
doi = "10.1038/onc.2011.429",
language = "English (US)",
volume = "31",
pages = "2521--2534",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "20",

}

TY - JOUR

T1 - Tissue transglutaminase links TGF-Β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer

AU - Cao, L.

AU - Shao, M.

AU - Schilder, J.

AU - Guise, T.

AU - Mohammad, K. S.

AU - Matei, D.

PY - 2012/5/17

Y1 - 2012/5/17

N2 - Tissue transglutaminase (TG2), an enzyme involved in cell proliferation, differentiation and apoptosis is overexpressed in ovarian carcinomas, where it modulates epithelial-to-mesenchymal transition (EMT) and promotes metastasis. Its regulation in ovarian cancer (OC) remains unexplored. Here, we show that transforming growth factor (TGF)-Β, a cytokine involved in tumor dissemination is abundantly secreted in the OC microenvironment and induces TG2 expression and enzymatic activity. This is mediated at transcriptional level by SMADs and by TGF-Β-activated kinase 1-mediated activation of the nuclear factor-B complex. TGF-Β-stimulated OC cells aggregate as spheroids, which enable peritoneal dissemination. We show that TGF-Β-induced TG2 regulates EMT, formation of spheroids and OC metastasis. TG2 knock-down in OC cells decreases the number of cells harboring a cancer stem cell phenotype (CD44 +CD117+). Furthermore, CD44 +CD117+ cells isolated from human ovarian tumors express high levels of TG2. In summary, TGF-Β-induced TG2 enhances ovarian tumor metastasis by inducing EMT and a cancer stem cell phenotype.

AB - Tissue transglutaminase (TG2), an enzyme involved in cell proliferation, differentiation and apoptosis is overexpressed in ovarian carcinomas, where it modulates epithelial-to-mesenchymal transition (EMT) and promotes metastasis. Its regulation in ovarian cancer (OC) remains unexplored. Here, we show that transforming growth factor (TGF)-Β, a cytokine involved in tumor dissemination is abundantly secreted in the OC microenvironment and induces TG2 expression and enzymatic activity. This is mediated at transcriptional level by SMADs and by TGF-Β-activated kinase 1-mediated activation of the nuclear factor-B complex. TGF-Β-stimulated OC cells aggregate as spheroids, which enable peritoneal dissemination. We show that TGF-Β-induced TG2 regulates EMT, formation of spheroids and OC metastasis. TG2 knock-down in OC cells decreases the number of cells harboring a cancer stem cell phenotype (CD44 +CD117+). Furthermore, CD44 +CD117+ cells isolated from human ovarian tumors express high levels of TG2. In summary, TGF-Β-induced TG2 enhances ovarian tumor metastasis by inducing EMT and a cancer stem cell phenotype.

KW - cancer stem cells

KW - epithelial to mesenchymal transition

KW - metastasis

KW - ovarian cancer

KW - TG2

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=84861344069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861344069&partnerID=8YFLogxK

U2 - 10.1038/onc.2011.429

DO - 10.1038/onc.2011.429

M3 - Article

C2 - 21963846

AN - SCOPUS:84861344069

VL - 31

SP - 2521

EP - 2534

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 20

ER -